Bacterial Infections in Chilean Rose Tarantulas
Invertebrate · Grammostola rosea · typical adult weight 0.01–0.10 kg
2 cited drugs treat Bacterial Infections in chilean rose tarantulas: Ceftazidime, Enrofloxacin.
General coverage of susceptible bacterial pathogens. Drug selection turns on the suspected organism's gram-stain, the patient's species (oral β-lactams unsafe in rabbits/guinea pigs), and the infection site (penetration to bone, CSF, or biliary tree).
The overview above describes Bacterial Infections across species; the citations below are the ExoticRx dose rules scoped to chilean rose tarantulas — a reference list, not new species-specific clinical guidance.
Ceftazidime(Fortaz)
Antibiotic| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| intracardiac | 20 mg/kg | q72h | 3 weeks | Gram-negative bacterial infection | Weak | Invertebrate Medicine, 3rd ed (Lewbart, 2022), Table 33.2 "Arthropoda - Arachnida", corpus PDF p.1956, citing Pizzi (2012). Published 2026-08-06. — SOURCE EDITION: Invertebrate Medicine — ISBN 9781119569435, https://openlibrary.org/isbn/9781119569435 |
Enrofloxacin(Baytril)
Antibiotic| Route | Dose | Frequency | Indication | Evidence | Source |
|---|---|---|---|---|---|
| IV | 5 mg/kg | once | Bacterial infection | Weak | Invertebrate Medicine, 3rd ed (Lewbart, 2022), Table 33.2 "Arthropoda - Arachnida", corpus PDF p.1956, citing Pizzi (2012). Published 2026-08-06. — SOURCE EDITION: Invertebrate Medicine — ISBN 9781119569435, https://openlibrary.org/isbn/9781119569435 |
| PO | 10–20 mg/kg | q24h | Bacterial infection | Weak | Invertebrate Medicine, 3rd ed (Lewbart, 2022), Table 33.2 "Arthropoda - Arachnida", corpus PDF p.1956, citing Pizzi (2012). Published 2026-08-06. — SOURCE EDITION: Invertebrate Medicine — ISBN 9781119569435, https://openlibrary.org/isbn/9781119569435 |
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice. Verify against current literature before clinical use.